Canine adenovirus type 2 (CAV-2) is an important respiratory pathogen of dogs and has also emerged as a promising non-human adenoviral vector for gene delivery. However, antibody reagents targeting the CAV-2 penton base remain poorly characterized compared with those directed against the hexon and fiber proteins. In this study, we generated and characterized a mouse monoclonal antibody (mAb), designated 3D5, against the CAV-2 penton base. Recombinant penton base protein expressed in Escherichia coli was used for mouse immunization and hybridoma screening. mAb 3D5 was identified as an IgG2b antibody with a kappa light chain and specifically recognized both recombinant penton base protein and viral antigen in CAV-2-infected MDCK cells by Western blotting and immunofluorescence assays. Sequential truncation mapping localized the antibody-binding region to the N terminus of the penton base, and a recombinant fragment spanning residues 29–36 (RYKGATEG) retained 3D5 reactivity under denaturing conditions. This sequence was identical in 31/33 CAV-2 and 4/4 CAV-1 accession records, and mAb 3D5 reacted with a recombinant CAV-1 preparation. MAb 3D5 showed no neutralizing activity. These results identify a N-terminal linear reactive region recognized by mAb 3D5 and provide a renewable monoclonal antibody reagent for CAV-2 antigen detection and further investigation of penton base antigenicity.